ClinicalTrials.gov record
Completed Phase 1 Interventional Accepts healthy volunteers Results available

Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers

ClinicalTrials.gov ID: NCT02167594

Public ClinicalTrials.gov record NCT02167594. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 9:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers

Study identification

NCT ID
NCT02167594
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Avid Radiopharmaceuticals
Industry
Enrollment
29 participants

Conditions and interventions

Interventions

  • Brain PET scan Procedure
  • Flortaucipir F18 Drug

Procedure · Drug

Eligibility (public fields only)

Age range
50 Years to 85 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 11, 2014
Primary completion
Jul 10, 2016
Completion
Jul 10, 2016
Last update posted
Aug 27, 2020

2014 – 2016

United States locations

U.S. sites
5
U.S. states
4
U.S. cities
5
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
UCSD Movement Disorder Clinic La Jolla California 92037
UCSF Neurosciences Clinical Research Unit San Francisco California 94158
Molecular Neuroimaging New Haven Connecticut 06510
Perelman School of Medicine Philadelphia Pennsylvania 19104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02167594, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 27, 2020 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02167594 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →